DDAVP (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the DDAVP drug offered from sanofi-aventis U.S. LLC. This Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
NON-PROPRIETARY NAME: | desmopressin acetate |
SUBSTANCE NAME: | DESMOPRESSIN ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1984-03-30 |
END MARKETING DATE: | 0000-00-00 |
DDAVP HUMAN PRESCRIPTION DRUG Details:
Item Description | DDAVP from sanofi-aventis U.S. LLC |
LABELER NAME: | sanofi-aventis U.S. LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(ug/mL) |
START MARKETING DATE: | 1984-03-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0075-2451_5e30ba6d-ebb3-4950-b03a-7f1e946da982 |
PRODUCT NDC: | 0075-2451 |
APPLICATION NUMBER: | NDA018938 |
Other DESMOPRESSIN ACETATE Pharmaceutical Manufacturers / Labelers: